Prednisone Completed Phase 3 Trials for Duchenne's Muscular Dystrophy (DMD) Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00004646Phase III Randomized, Double-Blind Study of Prednisone for Duchenne Muscular Dystrophy
NCT00110669High-dose Prednisone in Duchenne Muscular Dystrophy